DUSA Pharmaceuticals, Inc. (NasdaqUSA) announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13, 2011 at 10:25 a.m. ET at The Waldorf Astoria Hotel in New York City. Interested parties can access the live audio webcast of the presentation at www.dusapharma.com.

DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions primarily in the United States, Canada, and Korea.

To read more at : http://doubleinstocks.com/?p=18481